Skip to content
Article Rich – Lifestyle
Author:
AtomVie Global Radiopharma Inc.
AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics’ Phase 1/2a Clinical Study of 177Lu-BetaBart (RV-01)
March 4, 2026